Drugs
#Brexit with no deal risks chaos in drug supply, report warns
Crashing out of the European Union without a deal would cause major problems for Britain’s health service and risk “chaotic disruption” to medicine supplies, according to a report on Tuesday (7 November).
And it could create particular problems for healthcare in Northern Ireland, where treatment programmes for some rare and serious diseases are designed to work across the entire island of Ireland.
“A scenario where the UK leaves without any deal would cause extensive problems for the NHS. It would risk a chaotic disruption to supplies of medical products, and a rise in prices that would push hospitals deeper into deficit,” the report stated.
“Many different parts of EU law and EU institutions play an important role in enabling care to be delivered to the standards we see today. Suddenly ending them with no replacement would do serious damage to an already strained British NHS.”
The warning chimes with concerns from pharmaceutical companies, which are already drawing up plans to protect supply chains.
Stringent medicine regulations mean manufacturers face multiple Brexit uncertainties, such as the potential need to retest drugs shipped across borders and transfer product licences to different jurisdictions.
Share this article:
-
Green Deal5 days ago
Heat pumps crucial to green transition for steel and other industries
-
Motoring3 days ago
Fiat 500 vs. Mini Cooper: A Detailed Comparison
-
Horizon Europe3 days ago
Swansea academics awarded €480,000 Horizon Europe grant to support new research and innovation project
-
Lifestyle3 days ago
Transforming Your Living Room: A Glimpse into the Future of Entertainment Tech